| 1VAQ | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | 1GL, ARI, CDR, CPH, ERI, MG | enzyme |
| ||||||||||||
| Primary reference | Crystal structure of the [Mg2+-(chromomycin A3)2]-d(TTGGCCAA)2 complex reveals GGCC binding specificity of the drug dimer chelated by a metal ion., Hou MH, Robinson H, Gao YG, Wang AH, Nucleic Acids Res 2004 Apr 23;32(7):2214-22. Print 2004. PMID:15107489 | ||||||||||||||
| Data retrieval |
![]() |
| View 1VAQ in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |